THERESA T VO

Allopathic & Osteopathic Physicians|Dermatology ROWLETT, TX NPI 1437592151

General Payments — all program years on this page

$1,671.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 62
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $565.65 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $466.6520
Education $99.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $17.421
2019 $240.282
2022 $364.5916
2023 $483.3522
2024 $565.6521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078753852 Janssen Biotech, Inc. $23.43 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078753876 Janssen Biotech, Inc. $99.00 02/16/2024 Education Undisputed 01/23/2026 View at CMS
1078753892 Janssen Biotech, Inc. $32.24 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087352726 Novartis Pharmaceuticals Corporation $22.35 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101865315 E.R. Squibb & Sons, L.L.C. $17.44 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101865420 E.R. Squibb & Sons, L.L.C. $17.05 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114239323 Regeneron Healthcare Solutions, Inc. $20.15 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117710678 Amgen Inc. $27.74 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121076185 Arcutis Biotherapeutics, Inc. $21.11 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121076187 Arcutis Biotherapeutics, Inc. $17.05 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127944012 Dermavant Sciences, Inc. $18.53 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127944014 Dermavant Sciences, Inc. $16.73 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135437611 Lilly USA, LLC $24.93 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135490738 Lilly USA, LLC $23.88 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139932863 GENZYME CORPORATION $28.81 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139932947 GENZYME CORPORATION $21.57 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152654935 LEO Pharma Inc. $25.82 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152654937 LEO Pharma Inc. $29.31 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152654939 LEO Pharma Inc. $27.54 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154661359 MAYNE PHARMA COMMERCIAL LLC $23.23 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154661361 MAYNE PHARMA COMMERCIAL LLC $27.74 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.